Caricamento...
CAR-T cell therapy: current limitations and potential strategies
Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary new pillar in cancer treatment. Although treatment with CAR-T cells has produced remarkable clinical responses with certain subsets of B cell leukemia or lymphoma, many challenges limit the therapeutic efficacy of CAR-T cells in solid...
Salvato in:
| Pubblicato in: | Blood Cancer J |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8024391/ https://ncbi.nlm.nih.gov/pubmed/33824268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00459-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|